Combination of Diosmetin With Chrysin Against Hepatocellular Carcinoma Through Inhibiting <scp>PI3K</scp>/<scp>AKT</scp>/<scp>mTOR</scp>/<scp>NF</scp>‐<scp>кB</scp> Signaling Pathway: <scp>TCGA</scp> Analysis, Molecular Docking, Molecular Dynamics, In Vitro Experiment
Yu Xiang(Wuhan Polytechnic University), Lingyun Xu(Wuhan Polytechnic University), Chengming Hu(Wuhan Polytechnic University), Di Zhang(Beijing University of Chinese Medicine), Li Yang(Nanjing Medical University), Cheng Fang(SciencePharma (Poland)), Zhinan Mei(Huazhong Agricultural University), Zejun Yu(Wuhan Polytechnic University), Yinsheng Qiu(Wuhan Polytechnic University)
Cited by 2
Related Papers
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery
|Nature Protocols|2022|499
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457
Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes
|Journal of the American Chemical Society|2021|161
The Current Developments in Medicinal Plant Genomics Enabled the Diversification of Secondary Metabolites’ Biosynthesis
|International Journal of Molecular Sciences|2022|60